| Navie Persaud, | |
|
233 S Quintana Dr, Anaheim, CA 92807-4029 | |
| (714) 998-9817 | |
| Not Available |
| Full Name | Navie Persaud |
|---|---|
| Gender | Female |
| Speciality | Licensed Vocational Nurse |
| Location | 233 S Quintana Dr, Anaheim, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811219710 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164X00000X | Licensed Vocational Nurse | VN194908 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Navie Persaud, 233 S Quintana Dr, Anaheim, CA 92807-4029 Ph: () - | Navie Persaud, 233 S Quintana Dr, Anaheim, CA 92807-4029 Ph: (714) 998-9817 |
News Archive
Cancer remains a deadly threat despite the best efforts of science. New hopes were raised a few years ago with the discovery that the uncontrolled growth of cancer cells could be thwarted by blocking the action of proteasomes. Biochemists at the Technische Universitaet Muenchen (TUM) have illuminated a reaction pathway that does just that, in collaboration with researchers from Nereus Pharmaceuticals, based in San Diego, California. In the current issue of the Journal of Medicinal Chemistry, they report insights that could potentially lead to the development of custom-tailored anti-cancer drugs.
GlaxoSmithKline (NYSE:GSK) and XenoPort, Inc. (Nasdaq:XNPT) today announced top-line results from a Phase IIb clinical trial evaluating the safety and efficacy of GSK1838262/XP13512 (gabapentin enacarbil) for neuropathic pain associated with post-herpetic neuralgia (PHN) in adults.
Researchers at Rhode Island Hospital, Veterans Affair Medical Center in Providence and University of Rhode Island have found that a free fatty acid, made up of compounds similar to those naturally made in the body, may be as effective at fighting certain infections as antibiotics.
BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins, today announced that it has entered into a research agreement with Roche to discover novel nanomedicines using Accurins for the treatment of diseases in therapeutic areas outside of oncology.
SARAH, a large French study of patients with advanced, inoperable primary liver cancer (hepatocellular carcinoma, or HCC) has completed patient enrolment, exceeding its 400-patient target, according to its principal investigator, Professor Valérie Vilgrain MD, PhD, Department of Radiology, Beaujon Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP) and Université Paris Diderot, Sorbonne Paris Cité, France.
› Verified 8 days ago
Ivon Morales, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 1360 S Anaheim Blvd Ste 101, Anaheim, CA 92805 Phone: 714-948-7641 | |
Maria Pilar Ng, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2026 W Beacon Ave, Anaheim, CA 92804 Phone: 657-276-7030 | |
Lynette G Armstrong, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2531 W Woodland Dr, Anaheim, CA 92801 Phone: 714-226-9888 Fax: 714-226-9887 | |
Carmelina A Lopez, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2026 W Beacon Ave, Anaheim, CA 92804 Phone: 657-276-7030 | |
Alejandra Geraldine Guzman Torres, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 918 W Romneya Dr Apt 7, Anaheim, CA 92801 Phone: 714-803-3701 | |
Roy Santiago Adeva, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 222 S Camphor St, Anaheim, CA 92805 Phone: 714-234-8427 | |
Mr. Allan Bautista, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 1772 W Colonial Ave, Anaheim, CA 92804 Phone: 714-609-2150 |